Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

FDA grants fast track status for CDP-571

Sep. 10, 1998

Allelix GI drug moves into the clinic

Sep. 10, 1998

Positive clinical trial results reported for HTF-919

Sep. 7, 1998

FDA clears Intron A for pediatric chronic hepatitis B

Sep. 4, 1998

Novel agents for irritable bowel syndrome in early development at Kyorin

Sep. 1, 1998

Chugai investigates macrolide compounds as prokinetic agents

Sep. 1, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

Rebetron receives priority review status

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

Il Yang synthesizes gastric H+/K+-ATPase inhibitors with improved stability

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...